(Q40621708)

22 September 2017

Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals (English)

1 reference

22 September 2017

Binding and Neutralization Activity of Human IgG1 and IgG3 from Serum of HIV-Infected Individuals (English)

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

26 March 2024

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

26 March 2024

author name string

David Kuhrt

2

1 reference

22 September 2017

Mark Duval

3

1 reference

22 September 2017

Kenneth Mayer

4

1 reference

22 September 2017

Lisa A. Cavacini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585209

26 March 2024

Marshall R. Posner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14585209

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585209

26 March 2024

publication date

1 September 2003

1 reference

full work available at URL

22 September 2017

http://www.liebertpub.com/doi/pdf/10.1089/088922203769232584

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

AIDS Research and Human Retroviruses

26 March 2024

published in

1 reference

22 September 2017

19

1 reference

22 September 2017

9

1 reference

22 September 2017

785-792

1 reference

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

22 September 2017

2

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

26 March 2024

3

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Journal of Acquired Immune Deficiency Syndromes

26 March 2024

4

10

1093

Cavacini L

1993

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades.

26 March 2024

5

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1

26 March 2024

9

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies

26 March 2024

11

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

26 March 2024

13

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

26 March 2024

16

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

26 March 2024

18

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1.

26 March 2024

19

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1.

26 March 2024

20

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.

26 March 2024

21

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

The antigenic structure of the HIV gp120 envelope glycoprotein

26 March 2024

22

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding

26 March 2024

23

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Journal of Acquired Immune Deficiency Syndromes

26 March 2024

26

5

591

Thali M

1992

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Diagnostic and clinical immunology

26 March 2024

27

5

115

Normansell DE

1987

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance.

26 March 2024

29

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Genetically engineered immunoglobulins reveal structural features controlling segmental flexibility

26 March 2024

31

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.

26 March 2024

33

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies

26 March 2024

36

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees

26 March 2024

38

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants

26 March 2024

39

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Isotypic distribution of HIV-1-specific antibodies in individuals from central Africa

26 March 2024

40

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Isotypic restriction of the antibody response to human immunodeficiency virus

26 March 2024

41

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression

26 March 2024

42

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1.

26 March 2024

43

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

IgG subclass responses to human immunodeficiency virus-1 antigens: lack of IgG2 response to gp41 correlates with clinical manifestation of disease

26 March 2024

44

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Phase I Study of a Human Monoclonal Antibody Directed against the CD4-Binding Site of HIV Type 1 Glycoprotein 120

26 March 2024

47

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Journal of Acquired Immune Deficiency Syndromes

26 March 2024

48

6

353

Cavacini L

1993

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins

26 March 2024

49

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Engineering monoclonal antibodies to determine the structural requirements for complement activation and complement mediated lysis

26 March 2024

51

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Activation of complement by an IgG molecule without a genetic hinge

26 March 2024

52

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells

26 March 2024

53

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

26 March 2024

Monographs in allergy

54

23

27

Linde A

1988

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects

26 March 2024

55

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression

26 March 2024

57

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids

26 March 2024

58

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.

26 March 2024

59

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Measles virus-specific immunoglobulin G isotype immune response in early and late infections

26 March 2024

60

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection

26 March 2024

61

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Mechanism and regulation of immunoglobulin isotype switching.

26 March 2024

62

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3

26 March 2024

63

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

Towards a comprehensive view of immunoglobulin class switching

26 March 2024

65

1 reference

https://api.crossref.org/works/10.1089/088922203769232584

26 March 2024

Identifiers

1 reference

22 September 2017

1 reference